Ensuring the involvement of children in the evaluation of new tuberculosis treatment regimens.

Ensuring the involvement of children in the evaluation of new tuberculosis treatment regimens.

Saved in:

Bibliographic Details
Main Authors:	William J Burman, Mark F Cotton, Diana M Gibb, A Sarah Walker, Andrew A Vernon, Peter R Donald
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2008-08-01
Series:	PLoS Medicine
Online Access:	https://doi.org/10.1371/journal.pmed.0050176
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Non-Injection Chemotherapy Regimens for Drug Resistant Tuberculosis in Children and Adolescents
by: V. A. Aksenova, et al.
Published: (2023-12-01)

Standardized treatment of active tuberculosis in patients with previous treatment and/or with mono-resistance to isoniazid: a systematic review and meta-analysis.
by: Dick Menzies, et al.
Published: (2009-09-01)

Safety of new tuberculosis treatment regimens and compliance with these regimens according to data from the Republic of Kazakhstan
by: Zh. T. Zhandauletova, et al.
Published: (2023-03-01)

Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis.
by: Dick Menzies, et al.
Published: (2009-09-01)

Toxicity of treatment regimens for drugresistant tuberculosis.
by: G. N. Mozhokina, et al.
Published: (2022-03-01)

Treatment of young children with HIV infection: using evidence to inform policymakers.
by: Andrew J Prendergast, et al.
Published: (2012-01-01)

Efficacy of standard chemotherapy regimens in children and adolescents suffering from respiratory tuberculosis
by: E. F. Luginova, et al.
Published: (2020-12-01)

Tolerability of individual chemotherapy regimens in children suffering from respiratory tuberculosis and exposed to multiple and extensive drug resistant tuberculosis
by: M. F. Gubkinа, et al.
Published: (2021-04-01)

Recent advancements in tuberculosis (TB) treatment regimens
by: Shyamala Ravikoti, et al.
Published: (2025-02-01)

ECONOMIC FEASIBILITY OF NEW CHEMOTHERAPY REGIMENS FOR TREATMENT OF TUBERCULOSIS PATIENTS WITH EXTENSIVE DRUG RESISTANCE
by: I. A. Vasilyeva, et al.
Published: (2018-07-01)

Biotransformation enzymes for xenobiotics and personalization of treatment regimens for tuberculosis patients
by: G. N. Mozhokina, et al.
Published: (2016-04-01)

Eﬃcacy and safety of short course chemotherapy regimens in older children and adolescents with multiple and extensive drug resistant respiratory tuberculosis
by: L. V. Panova, et al.
Published: (2021-11-01)

Designing molecular diagnostics for current tuberculosis drug regimens
by: Sophia B. Georghiou, et al.
Published: (2023-12-01)

Economic aspects of using new chemotherapy regimens for multidrug and extensively drugresistant tuberculosis
by: А. V. Kukurika
Published: (2022-10-01)

ADVERSE SIDE EFFECTS OF TUBERCULOSIS ETIOTROPIC TREATMENT REGIMENS CONTAINING THE NEW ANTI-TUBERCULOSIS DRUG OF SQ109
by: S. E. Borisov
Published: (2018-08-01)

CLINICAL CASES OF FOCAL PULMONARY TUBERCULOSIS IN CHILDREN WITH MINIMUM INVOLVEMENT IN MULTIDRUG RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS
by: M. F. Gubkina, et al.
Published: (2015-03-01)

Comparative analysis of eﬃcacy and safety of various anti-tuberculosis therapy regimens in patients with MDR/XDR tuberculosis
by: E. P. Myshkova, et al.
Published: (2022-06-01)

Tuberculosis Involving the Oral Cavity
by: Kathleen A Ferguson, et al.
Published: (1993-01-01)

Rapid antiretroviral therapy initiation in low- and middle-income countries: A resource-based approach.
by: Mark W Tenforde, et al.
Published: (2019-01-01)

Contemporary approaches to the search for active drugs and chemotherapy regimens for tuberculosis treatment
by: T. K. Lugovkinа, et al.
Published: (2020-07-01)

Short-Course Chemotherapy Regimens for Treatment of Multiple and Pre-Extensive Drug Resistant Tuberculosis in Combination with Surgery in Older Children and Adolescents
by: E. S. Ovsyankina, et al.
Published: (2024-12-01)

The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South Africa.
by: Gwenan M Knight, et al.
Published: (2015-01-01)

EXPERIENCE OF TREATING MULTIPLE AND EXTENSIVE DRUG RESISTANT TUBERCULOSIS WITH NEW REGIMENS IN BELARUS REPUBLIC
by: E. M. Skryagina, et al.
Published: (2018-09-01)

Cellular and Humoral Mechanisms Involved in the Control of Tuberculosis
by: Joaquin Zuñiga, et al.
Published: (2012-01-01)

INDIVIDUAL APPROACHES TO THE CHOICE OF CHEMOTHERAPY REGIMENS FOR RESPIRATORY TUBERCULOSIS IN CHILDREN EXPOSED TO MULTIPLE DRUG RESISTANT TUBERCULOUS INFECTION
by: M. F. Gubkina, et al.
Published: (2016-09-01)

Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model.
by: Emily A Kendall, et al.
Published: (2017-01-01)

Heterogeneity of Mycobacterium tuberculosis drug resistance in respect of pharmacokinetics of anti-tuberculosis drugs as a basis for individual treatment regimen
by: S. A. Popov, et al.
Published: (2015-04-01)

Clinical Efficacy and Safety of Clofazimine in Treatment Regimens for Drug Resistant Tuberculosis (Meta-Analysis)
by: A. I. Gayda, et al.
Published: (2024-05-01)

Safety of treatment regimens in multiple drug resistant tuberculosis patients compiled as per the new WHO recommendations as of 2019
by: D. A. Ivanova, et al.
Published: (2020-02-01)

Lifesaving, cost-saving: Innovative simplified regimens for drug-resistant tuberculosis.
by: Aastha Gupta, et al.
Published: (2022-01-01)

Efficacy and safety of chemotherapy regimens with bedaquiline in patients with respiratory tuberculosis: immediate and final results
by: S. E. Borisov, et al.
Published: (2019-05-01)

An overview of the new rifampicin-resistant tuberculosis regimens available at decentralised drug-resistant tuberculosis sites for persons older than six years
by: Madeleine Muller
Published: (2020-02-01)

Diagnostic dilemma of a new endobronchial lesion in a patient on anti-tuberculosis regimen: unveiling tuberculosis immune reconstitution inflammatory syndrome
by: Ming Ren Toh, et al.
Published: (2025-05-01)

COVID-19 pandemic and tuberculosis: How to ensure adequate care in pediatric age
by: M. Barros, et al.
Published: (2022-11-01)

Pretomanid: Clinical Trials and Prospects to Be Used in Treatment Regimens for Multiple and Extensive Drug Resistant Tuberculosis
by: A. V. Kukurika
Published: (2021-07-01)

Adequacy of recommendations for adverse event management in national and international treatment guidelines for rifampicin-susceptible tuberculosis: a systematic reviewResearch in context
by: William Burman, et al.
Published: (2025-04-01)

Short course treatment regimens for multiple drug resistant tuberculosis in Arkhangelsk, Murmansk and Belgorod Regions
by: A. О. Mаryandyshev, et al.
Published: (2019-08-01)

Newer regimen for drug resistant-tuberculosis: A ray of hope or threatening shadows
by: Vibha Mehta, et al.
Published: (2025-05-01)

Cost analysis of the TB-PRACTECAL clinical trial on novel tuberculosis treatment regimens.
by: Dzintars Gotham, et al.
Published: (2025-01-01)

Approaches to Selection of Optimal Chemotherapy Regimens in Tuberculosis Patients with Concurrent Diabetes Mellitus
by: O. G. Komissarova, et al.
Published: (2023-12-01)